Open AccessSafety, diagnostic accuracy and therapeutic efficacy of digital single‐operator cholangioscopy
Author(s) -
Lenze Frank,
Bokemeyer Arne,
Gross Dina,
Nowacki Tobias,
Bettenworth Dominik,
Ullerich Hansjoerg
Publication year - 2018
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640618764943
Subject(s) - medicine , operator (biology) , medical physics , radiology , biochemistry , chemistry , gene , repressor , transcription factor
Background Digital single‐operator cholangioscopes (digital SOCs), equipped with an improved image quality, have been recently introduced. Objective The aim of this study is to evaluate the safety and diagnostic and therapeutic efficacy of digital SOCs (Spyglass™ DS). Methods Sixty‐seven digital SOC procedures performed between 2015 and 2017 were retrospectively analyzed. Results The most frequent indications for examination were indeterminate biliary strictures (61.2%) and biliary stone disease (23.9%). In 25 patients (37.3), visual findings predicted malignancy with a sensitivity of 88.9%, a specificity of 97.6%, a positive predictive value (PPV) of 96.0% and a negative predictive value (NPV) of 92.9%. For histological analysis, forceps biopsies were performed in 29 patients (43.2%). Compared with visual findings, forceps biopsies yield a lower diagnostic efficacy in diagnosing malignancy (sensitivity 62.5%, specificity 90.0%, PPV 90.9%, NPV 60.0%). Therapeutic interventions were performed in 19 patients with a technical success rate of 89.4%. Adverse events were observed in 17 patients (25.4%). Of these, 11 patients (16.4%) suffered from severe adverse events (pancreatitis, cholangitis or major bleeding), which led to a prolonged hospital stay. Conclusion Digital SOCs have excellent diagnostic and therapeutic efficacies, but are accompanied by high rates of adverse events; therefore, physicians should use digital SOCs in carefully selected cases.